Lineage Cell Therapeutics, Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
Lineage Cell Therapeutics, Inc. (LCTX) had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $24.70 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2026-08-06
- 2026-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $24.70M.
- 2026-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $34.14M.
- 2025-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $43.91M.
- 2025-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $45.17M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $24.70M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $34.14M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $43.91M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $45.17M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $18.80M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $6.06M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $6.16M 10-K · filed 2026-03-05 |
| 2024-11-21 | $7.90M 10-Q · filed 2025-05-13 |
| 2023-06-30 | $1.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $2.00K 10-K · filed 2024-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |